
Richard Finkel
Director, Center for Experimental Neurotherapeutics · St Jude Children's Research Hospital
Credentials: · · · ·
History
PresentCenter for Experimental Neurotherapeutics · St Jude Children's Research Hospital


1981–1985
Research
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
New England Journal of Medicine · 2017 · First of 22 authors · 1,769 citations
Review · The Lancet Neurology · 2010 · 1,430 citations
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
New England Journal of Medicine · 2018 · 1,080 citations
- BD
72 papers

58 papers

56 papers

54 papers
- AP
34 papers

30 papers

29 papers
- GT
27 papers
Grants
- 2008–2012
Stakeholders' Views on Research Design: The Duchenne Muscular Dystrophy Community
National Institute of Neurological Disorders and Stroke · R21
Contact PI · $215.9K · Children's Hosp of Philadelphia
Clinical trials
- 2026–2033
A Registry of Cases of Spinal Muscular Atrophy
Principal investigator · Recruiting
St. Jude Children's Research Hospital
- 2025–2028
Principal investigator · Recruiting
St. Jude Children's Research Hospital
- 2025–2029
Nemaline Myopathy Clinical Research Network (NM-CTRN)
Principal investigator · Not yet recruiting
Stanford University
- 2008–2009
A Pilot Study of Biomarkers for Spinal Muscular Atrophy
Principal investigator · Completed
Carelon Research


